FOLLOW US

  • facebook
  • twitter
Sun

March 22, 2026

Gilead to acquire Arcellx

America February 23, 2026

Gilead to Acquire Arcellx in $7.8B Biotech Bet on Cancer Therapy

In a high-stakes move that could reshape the cancer treatment landscape, Gilead to acquire Arcellx became the headline Monday as…

By Rihem Akkouche

Ipsen to acquire ImCheck Therapeutics

America October 22, 2025

Ipsen to acquire ImCheck Therapeutics For €1B

In a sweeping expansion of its cancer drug portfolio, global biopharmaceutical powerhouse Ipsen SAS announced Wednesday that it will acquire…

By Rihem Akkouche

Genmab to acquire Merus

America September 29, 2025

Genmab to Acquire Merus in $8 Billion Biotech Deal

In a high-stakes gamble that could reshape the oncology landscape, Danish biotechnology powerhouse Genmab AS announced Monday it will acquire…

By Rihem Akkouche

AbbVie $2B Licensing Agreement

America July 10, 2025

AbbVie Strikes $2B Licensing Deal with IGI Therapeutics

In a move that signals intensifying ambitions in the cancer therapeutics arena, pharmaceutical titan AbbVie Inc. unveiled Thursday a blockbuster…

By Rihem Akkouche

BioNTech To acquire CureVac

America June 12, 2025

BioNTech to Acquire CureVac in $1.25B Deal

In a bold move that could redefine the future of mRNA-driven cancer therapies, German biotech giant BioNTech SE announced Thursday…

By Rihem Akkouche

Taiho to acquire Araris Biotech

America March 17, 2025

Taiho to Acquire Araris Biotech in $1.14B Deal

In a high-stakes move set to reshape the biotech landscape, Taiho Pharmaceutical Co. Ltd. announced Monday that it will acquire…

By Rihem Akkouche

Jazz Pharmaceuticals to Acquire Chimerix

America March 5, 2025

Jazz Pharmaceuticals to Acquire Chimerix for $935M

In a move set to reshape the oncology market, Jazz Pharmaceuticals announced Wednesday its plans to acquire Chimerix in a…

By Rihem Akkouche

GSK completes acquisition of IDRx

America February 24, 2025

GSK Completes Acquisition of IDRx

Pharmaceutical giant GSK has officially sealed its acquisition of biopharma company IDRx Inc. in a high-stakes $1.15 billion deal aimed…

By Rihem Akkouche

Redx Pharma $880m deal with Jazz Pharma

America February 7, 2024

Redx Pharma $880M Deal With Jazz Pharma

Biotechnology innovator Redx Pharma PLC announced a groundbreaking agreement on Wednesday, entailing the transfer of global rights for the advancement…

By Rihem Akkouche

Novartis to Buy MorphoSys In €2.7B Deal

America February 6, 2024

Novartis to Buy MorphoSys In €2.7B Deal

In a strategic move to bolster its oncology treatment options, Novartis AG, the Swiss pharmaceutical juggernaut, has inked a monumental…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter